Patent Assignment
Reel/Frame 031159/0636
Release of Security Interest
Recorded: 2013-09-03
Pages: 28
Assignor
PAUL CAPITAL FUND MANAGEMENT, L.L.C.
Executed: 2013-08-30
Assignee
ROMARK LABORATORIES, L.C.
3000 BAYPORT DRIVE, SUITE 200, TAMPA, FLORIDA, 33607
Covered Properties
(24)
Controlled Release Pharmaceutical Formulations of Nitazoxanide
PCT:
PCT/US2010/024000 ↗
Haloalkyl Heteroaryl Benzamide Compounds
PCT:
PCT/US2010/034319 ↗
Compounds and Methods for Treating Influenza
PCT:
PCT/US2010/039638 ↗
Composition and Galenic Formulation Suitable for Combatting Affections of the Lower Abdomen
Patent:
5,387,598 →
Application:
08/227,033 →
Benzamide Derivatives
Patent:
5,578,621 →
Application:
08/301,407 →
Method for Treatment of Helicobacter Pylori Infections
Patent:
5,859,038 →
Application:
08/644,153 →
Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent:
5,968,961 →
Application:
08/852,447 →
Method Treatment of Opportunistic Infections with Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent:
5,965,590 →
Application:
08/887,809 →
Method for Treatment of Trematodes with Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent:
5,856,348 →
Application:
08/887,810 →
Method for Inhibiting Scale and Controlling Corrosion in Cooling Water Systems
Patent:
5,866,013 →
Application:
08/909,802 →
Method for Treatment of Equine Protozoal Myeloencephalitis with Thiazolides
Patent:
5,935,591 →
Application:
09/007,653 →
Acid Stabilized Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent:
6,117,894 →
Application:
09/073,436 →
Synthesis of Aryl Glucuronide of 2-Hydroxy-N- (5-Nitro-2-Thiazolyl) Benzamide, and Pharmaceutical Compositions Comprising Same
Patent:
5,925,622 →
Application:
09/114,596 →
2-(Hydroxy)-N-(5-Nitro-2-Thiazolyl)Benzamide
Patent:
6,020,353 →
Application:
09/170,697 →
Halogenated Benzamide Derivatives
Viral hepatitis treatment
Halogenated Benzamide Derivatives
Halogenated Benzamide Derivatives
Alkylsulfonyl-Substituted Thiazolide Compounds
Controlled Release Pharmaceutical Formulations of Nitazoxanide
Haloalkyl Heteroaryl Benzamide Compounds
Compounds and Methods for Treating Influenza
Pharmaceutical Compositions and Methods of Use of Salicylanilides for Treatment of Hepatitis Viruses
Application:
61/408,215 →
Alkylsulfinyl-Substituted Thiazolide Compounds
Application:
61/408,938 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 12, 2005
From: ROMARK LABORATORIES, L.C.
To: CARDINAL HEALTH, INC.
Reel/Frame 016513/0360 →
Security Agreement
Sep 26, 2006
From: ROMARK LABORATORIES, L.C.
To: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
Reel/Frame 018303/0163 →
Assignment of Assignor's Interest
Oct 24, 2006
From: ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 018428/0233 →
Termination of Security Interest
Mar 22, 2007
From: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 019047/0410 →
Notice of Grant of Security Interest
Mar 23, 2007
From: ROMARK LABORATORIES, L.C.
To: LAMINAR DIRECT CAPITAL L.P., AS COLLATERAL AGENT
Reel/Frame 019055/0317 →
Assignment of Assignor's Interest
Jan 14, 2008
From: ROSSIGNOL, JEAN FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 020358/0660 →
Assignment of Assignor's Interest
Jan 14, 2008
From: ROSSIGNOL, JEAN FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 020358/0710 →
Assignment of Assignor's Interest
Sep 5, 2008
From: ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 021487/0446 →
Assignment of Assignor's Interest
Sep 15, 2008
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 021530/0305 →
Notice of Grant of Security Interest in Patents
Sep 28, 2009
From: ROMARK LABORATORIES, L.C.
To: LAMINAR DIRECT CAPITAL, L.L.C., AS COLLATERAL AGENT
Reel/Frame 023282/0880 →
Assignment of Assignor's Interest
Feb 12, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; AYERS, MARC
To: ROMARK LABORATORIES L.C.
Reel/Frame 023976/0831 →
Assignment of Assignor's Interest
May 11, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 024364/0392 →
Assignment of Assignor's Interest
Jul 26, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 024737/0670 →
Assignment of Assignor's Interest
Jan 7, 2011
From: SEMPLE, J. EDWARD; ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 025600/0171 →
Release of Security Interest
Jul 15, 2011
From: CARDINAL HEALTH, INC.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026595/0901 →
Release of Security Interest
Jul 29, 2011
From: LAMINAR DIRECT CAPITAL, L.L.C. (SUCCESSOR IN INTEREST TO LAMINAR DIRECT CAPITAL L.P.)
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026676/0482 →
Change of Name
Jul 29, 2011
From: LAMINAR DIRECT CAPITAL L.P.
To: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
Reel/Frame 026676/0386 →
Change of Name
Jul 29, 2011
From: LAMINAR DIRECT CAPITAL L.P.
To: LAMINAR DIRECT CAPITAL, L.L.C.
Reel/Frame 026676/0247 →
Security Agreement
Jul 29, 2011
From: ROMARK LABORATORIES, L.C.
To: PAUL CAPITAL FUND MANAGEMENT, L.L.C.
Reel/Frame 026676/0635 →
Release of Security Interest
Jul 29, 2011
From: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026676/0576 →
Security Agreement
Sep 4, 2013
From: ROMARK LABORATORIES, L.C.; ROMARK MANUFACTURING, LLC; LAPICOR, N.V.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 031156/0923 →
Release of Security Interest
Mar 6, 2015
From: U.S. BANK NATIONAL ASSOCIATION
To: ROMARK LABORATORIES, L.C.; ROMARK MANUFACTURING, LLC; LAPICOR, N.V.
Reel/Frame 035108/0474 →
Security Interest
Dec 22, 2017
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 044472/0001 →
Security Interest
Jul 2, 2018
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 046254/0524 →
Security Interest
Nov 16, 2019
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 051030/0613 →